DK97288D0 - Antihypercholesterolemisk tetrazolforbindelse - Google Patents

Antihypercholesterolemisk tetrazolforbindelse

Info

Publication number
DK97288D0
DK97288D0 DK097288A DK97288A DK97288D0 DK 97288 D0 DK97288 D0 DK 97288D0 DK 097288 A DK097288 A DK 097288A DK 97288 A DK97288 A DK 97288A DK 97288 D0 DK97288 D0 DK 97288D0
Authority
DK
Denmark
Prior art keywords
antihypercholesterolemic
tetrazolic
compound
tetrazolic compound
antihypercholesterolemic tetrazolic
Prior art date
Application number
DK097288A
Other languages
English (en)
Other versions
DK97288A (da
DK174822B1 (da
Inventor
John J Wright
Sing-Yuen Sit
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of DK97288D0 publication Critical patent/DK97288D0/da
Publication of DK97288A publication Critical patent/DK97288A/da
Application granted granted Critical
Publication of DK174822B1 publication Critical patent/DK174822B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK198800972A 1987-02-25 1988-02-24 Antihypercholesterolæmiske tetrazolforbindelser, mellemprodukter og fremgangsmåde til fremstilling deraf DK174822B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US1854287A 1987-02-25 1987-02-25
US1854287 1987-02-25
US07/151,513 US4897490A (en) 1987-02-25 1988-02-18 Antihypercholesterolemic tetrazole compounds
US15151388 1988-02-18

Publications (3)

Publication Number Publication Date
DK97288D0 true DK97288D0 (da) 1988-02-24
DK97288A DK97288A (da) 1988-08-26
DK174822B1 DK174822B1 (da) 2003-12-08

Family

ID=26691223

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198800972A DK174822B1 (da) 1987-02-25 1988-02-24 Antihypercholesterolæmiske tetrazolforbindelser, mellemprodukter og fremgangsmåde til fremstilling deraf

Country Status (31)

Country Link
US (1) US4897490A (da)
JP (1) JP2603324B2 (da)
KR (1) KR960001203B1 (da)
CN (1) CN1026110C (da)
AT (1) AT395589B (da)
AU (1) AU1395088A (da)
BE (1) BE1002116A3 (da)
CA (1) CA1328268C (da)
CH (1) CH676848A5 (da)
CS (1) CS271481B2 (da)
DE (1) DE3805801C2 (da)
DK (1) DK174822B1 (da)
EG (1) EG18341A (da)
ES (2) ES2010246A6 (da)
FI (1) FI96601C (da)
FR (1) FR2612924B1 (da)
GR (1) GR1000472B (da)
HU (3) HU204516B (da)
IE (1) IE61619B1 (da)
IL (1) IL85529A (da)
IT (1) IT1216751B (da)
LU (1) LU87144A1 (da)
MX (1) MX9202847A (da)
MY (1) MY103214A (da)
NL (1) NL8800465A (da)
NO (1) NO169438C (da)
NZ (1) NZ223620A (da)
PT (1) PT86820B (da)
SE (1) SE503618C2 (da)
WO (1) WO1988006584A1 (da)
YU (1) YU36388A (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3741509A1 (de) * 1987-12-08 1989-06-22 Hoechst Ag Verfahren zur herstellung optisch aktiver 3-desmethylmevalonsaeurederivate sowie zwischenprodukte
GB2244705B (en) * 1988-02-18 1992-07-15 Bristol Myers Co Preparation of antihypercholesterolemic tetrazole compounds and intermediates thereof
US4824959A (en) * 1988-02-18 1989-04-25 Bristol-Myers Company Intermediates for antihypercholesterolemic tetrazole compounds
US4870187A (en) * 1988-08-23 1989-09-26 Bristol-Myers Company Antihypercholesterolemic tetrazol-1-yl compounds
US5010205A (en) * 1988-08-23 1991-04-23 Bristol-Myers Company Antihypercholesterolemic tetrazol-1-yl intermediates
US4927944A (en) * 1988-08-25 1990-05-22 Bristol-Myers Company Antihypercholesterolemic nitrile compounds
FI94339C (fi) 1989-07-21 1995-08-25 Warner Lambert Co Menetelmä farmaseuttisesti käyttökelpoisen /R-(R*,R*)/-2-(4-fluorifenyyli)- , -dihydroksi-5-(1-metyylietyyli)-3-fenyyli-4-/(fenyyliamino)karbonyyli/-1H-pyrroli-1-heptaanihapon ja sen farmaseuttisesti hyväksyttävien suolojen valmistamiseksi
US5413935A (en) * 1991-04-24 1995-05-09 E. R. Squibb & Sons, Inc. Process for selecting an enantiomer of a hydroxy lactone using pseudomonas lipase
US5134155A (en) * 1991-08-08 1992-07-28 Ortho Pharmaceutical Corporation Tetrahydroindazole, tetrahydrocyclopentapyrazole, and hexahydrocycloheptapyrazole compounds and their use as HMG-coA reductase inhibitors
US5986095A (en) * 1992-01-06 1999-11-16 E.R. Squibb & Sons, Inc. Enantioselective preparation of halophenyl alcohols and acylates
US5278313A (en) * 1992-03-27 1994-01-11 E. R. Squibb & Sons, Inc. Process for the preparation of 1,3-dioxane derivatives useful in the preparation of HMG-COA reductase inhibitors
US5324662A (en) * 1992-05-15 1994-06-28 E. R. Squibb & Sons, Inc. Stereoselective microbial or enzymatic reduction of 3,5-dioxo esters to 3-hydroxy-5-oxo, 3-oxo-5-hydroxy, and 3,5-dihydroxy esters
US5284957A (en) * 1992-09-03 1994-02-08 Eli Lilly And Company Excitatory amino acid receptor antagonists
JPH06329679A (ja) * 1993-01-20 1994-11-29 Nissan Chem Ind Ltd 光学活性β−アミノアルコキシボラン錯体
CA2137049A1 (en) * 1993-12-15 1995-06-16 John K. Thottathil Amino acid salts of and methods for preparing antihypercholesterolemic tetrazole compounds
DE19714343A1 (de) 1997-04-08 1998-10-15 Bayer Ag Chromatographische Enantiomerentrennung von Lactonen
NZ504346A (en) * 1997-12-19 2001-11-30 Warner Lambert Exp Ltd Process for the synthesis of 1,3-diols characterised by either reconcentration step with either trialkylborane or dialkylalkoxyborane or a mixture of both trialkylborane and dialkylalkoxyborane
DE10216967A1 (de) * 2002-04-16 2003-11-13 Bayer Ag Verfahren zur Herstellung spezieller aromatischer Aldehyde
EP2178890A1 (en) * 2007-07-12 2010-04-28 Teva Pharmaceutical Industries Ltd. Purification of rosuvastatin intermediate by thin film evaporation and chemical method
KR101681041B1 (ko) 2015-07-15 2016-12-22 경북대학교병원 ＥＲＲγ 비활성화 리간드로서의 신규한 방향족 고리 화합물 유도체

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4054666A (en) * 1973-03-23 1977-10-18 American Home Products Corporation Compositions and methods of treating immediate hypersensitivity reactions with thiazolyl oxamic acid derivatives
US4160100A (en) * 1973-03-23 1979-07-03 American Home Products Corporation Oxamic acid derivatives
US4013647A (en) * 1976-03-23 1977-03-22 American Home Products Corporation Morpholine containing tetrazole-5-carboxamide derivatives
JPS53147073A (en) * 1977-05-24 1978-12-21 Sankyo Co Ltd Mevalonolactone derivatives
US4567289A (en) * 1979-08-17 1986-01-28 Merck & Co., Inc. Substituted pyranone inhibitors of cholesterol synthesis
US4375475A (en) * 1979-08-17 1983-03-01 Merck & Co., Inc. Substituted pyranone inhibitors of cholesterol synthesis
NZ194557A (en) * 1979-08-17 1984-09-28 Merck & Co Inc Substituted pyranone derivatives;dihydroxy acids therefrom;pharmaceutical compositions
EP0068038B1 (en) * 1981-06-29 1985-09-25 Merck & Co. Inc. (+)-(4r,6s)-(e)-6-(2-(4'-fluoro-3,3',5-trimethyl-(1,1'-biphenyl)-2-yl)ethenyl)-3,4,5,6-tetrahydro-4-hydroxy-2h-pyran-2-one, a process for preparing and a pharmaceutical composition containing the same
WO1983002131A1 (en) * 1981-12-10 1983-06-23 Willy Bayer Internal combustion engine
WO1984002131A1 (en) * 1982-11-22 1984-06-07 Sandoz Ag Analogs of mevalolactone and derivatives thereof, processes for their production, pharmaceutical compositions containing them and their use as pharmaceuticals
US4739073A (en) * 1983-11-04 1988-04-19 Sandoz Pharmaceuticals Corp. Intermediates in the synthesis of indole analogs of mevalonolactone and derivatives thereof
ES8609193A1 (es) * 1983-01-24 1986-07-16 Sandoz Ag Procedimiento para preparar analogos de mevalonolactona y derivados de los mismos
CA1327360C (en) * 1983-11-14 1994-03-01 William F. Hoffman Oxo-analogs of mevinolin-like antihypercholesterolemic agents
US4613610A (en) * 1984-06-22 1986-09-23 Sandoz Pharmaceuticals Corp. Cholesterol biosynthesis inhibiting pyrazole analogs of mevalonolactone and its derivatives
KR890001651B1 (ko) * 1984-06-22 1989-05-12 산도즈 파마슈티칼스 코포레이션 메발로노락톤의 피라졸 동족체 및 이의 유도체의 제조방법
US4668794A (en) * 1985-05-22 1987-05-26 Sandoz Pharm. Corp. Intermediate imidazole acrolein analogs
US4621099A (en) * 1985-09-23 1986-11-04 Usv Pharmaceutical Corporation Polyene compounds useful in the treatment of allergic responses
US4681893A (en) * 1986-05-30 1987-07-21 Warner-Lambert Company Trans-6-[2-(3- or 4-carboxamido-substituted pyrrol-1-yl)alkyl]-4-hydroxypyran-2-one inhibitors of cholesterol synthesis
US4678806A (en) * 1986-09-02 1987-07-07 Merck & Co., Inc. Prodrugs of antihypercholesterolemic compounds

Also Published As

Publication number Publication date
PT86820A (pt) 1989-02-28
BE1002116A3 (fr) 1990-07-10
ES2010246A6 (es) 1989-11-01
FR2612924A1 (fr) 1988-09-30
YU36388A (en) 1989-10-31
AT395589B (de) 1993-01-25
FI880869A0 (fi) 1988-02-24
NO880809L (no) 1988-08-26
AU1395088A (en) 1988-09-26
IE61619B1 (en) 1994-11-16
IE880501L (en) 1988-08-25
SE8800638L (sv) 1988-09-21
ES2026746A6 (es) 1992-05-01
FR2612924B1 (fr) 1991-01-11
IT8819525A0 (it) 1988-02-24
US4897490A (en) 1990-01-30
EG18341A (en) 1993-08-30
NZ223620A (en) 1991-07-26
CA1328268C (en) 1994-04-05
DK97288A (da) 1988-08-26
JPH01502269A (ja) 1989-08-10
WO1988006584A1 (en) 1988-09-07
HU203329B (en) 1991-07-29
KR880009947A (ko) 1988-10-06
CS118088A2 (en) 1989-08-14
HUT47259A (en) 1989-02-28
DE3805801A1 (de) 1988-09-08
FI96601B (fi) 1996-04-15
MX9202847A (es) 1992-06-30
CH676848A5 (da) 1991-03-15
CN1026110C (zh) 1994-10-05
MY103214A (en) 1993-05-29
NO880809D0 (no) 1988-02-24
NO169438B (no) 1992-03-16
HU204038B (en) 1991-11-28
ATA46188A (de) 1992-06-15
IT1216751B (it) 1990-03-08
SE8800638D0 (sv) 1988-02-24
KR960001203B1 (ko) 1996-01-24
DK174822B1 (da) 2003-12-08
GR1000472B (el) 1992-07-30
FI96601C (fi) 1996-07-25
HU900669D0 (en) 1990-06-28
NO169438C (no) 1992-06-24
CN88100911A (zh) 1988-09-28
HU896737D0 (en) 1990-02-28
NL8800465A (nl) 1988-09-16
GR880100101A (en) 1988-12-16
SE503618C2 (sv) 1996-07-15
IL85529A0 (en) 1988-08-31
PT86820B (pt) 1995-03-01
LU87144A1 (fr) 1988-09-20
CS271481B2 (en) 1990-10-12
HU204516B (en) 1992-01-28
DE3805801C2 (de) 2001-03-01
JP2603324B2 (ja) 1997-04-23
FI880869A (fi) 1988-08-26
IL85529A (en) 1993-01-31

Similar Documents

Publication Publication Date Title
DK85993A (da) 2-anilino-4-formyl-pyrimidinforbindelser
BA98296A (bs) Piperazinil-heterociklicna jedinjenja
DE3751890D1 (de) Radionuklid-Antikörper-Verbindung
DE3855809D1 (de) Zusammengesetzter Supraleiter
BR8807217A (pt) Compostos heterocilicos
ATA30988A (de) Alpinski
DK594687D0 (da) Pyrrolidinylthioforbindelser
DK97288A (da) Antihypercholesterolemisk tetrazolforbindelse
ES2023238B3 (es) Montaje de fijacion
ATA174488A (de) Alpinski
ATA174288A (de) Alpinski
ATA224788A (de) Calcitoninsuppositorien
PT84187A (pt) Novel compounds
PT86766A (pt) Arylpiperazinyl-alkylene-phenyl-heterocyclic compounds
IT1221792B (it) Composti metossimetilici
DK187686A (da) Benzisothiazol-s-oxidforbindelse
JPS6463578A (en) Novel antihypercholesterolemic compound
DE3789797D1 (de) Pyrimidinylphenyl-Ester-Verbindung.
DK182487A (da) Octahydroquinolizinforbindelse
KR890700561A (ko) 살충성 시클로프로필-치환된 디 화합물
ATA294988A (de) Haecksler
DK182587D0 (da) 3-diphenyl-substituerede octahydroindolizinforbindelser
ATA175387A (de) Befestigungsband
KR880701715A (ko) 타우린- 형 화합물
SE8704372D0 (sv) New compound

Legal Events

Date Code Title Description
PBP Patent lapsed

Country of ref document: DK